Arsenic-induced neurotoxicity in relation to toxicokinetics: Effects on sciatic nerve proteins

Chemico-Biological Interactions

Volumn 176, Issue 2-3, 2008, Pages 188-195

  Vahidnia, A ^a   Romijn, F ^a   van der Voet, G B ^b   de Wolff, F A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Arsenite; Calpain; Microtubule associated protein tau; Neurofilament; Neurotoxicity; Phosphorylation

Indexed keywords

ARSENIC; ARSENITE SODIUM; CALPAIN 1; CALPAIN 2; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; KIDNEY CLEARANCE; MALE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SCIATIC NERVE; TOXICOKINETICS; WEIGHT CHANGE;

ANIMALS; ARSENITES; BODY WEIGHT; CALPAIN; MALE; NEUROFILAMENT PROTEINS; NEUROTOXINS; PERIPHERAL NERVOUS SYSTEM; PHOSPHORYLATION; RATS; RATS, WISTAR; SCIATIC NERVE; SODIUM COMPOUNDS; TISSUE DISTRIBUTION;

RATTUS; RATTUS NORVEGICUS;

EID: 55249112687     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.07.001     Document Type: Article

References (36)

1. Rahman M.M., Chowdhury U.K., Mukherjee S.C., Mondal B.K., Paul K., Lodh D., Biswas B.K., Chanda C.R., Basu G.K., Saha K.C., Roy S., Das R., Palit S.K., Quamruzzaman Q., and Chakraborti D. Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. J. Toxicol. Clin. Toxicol. 39 (2001) 683-700
2. Vahidnia A., van der Voet G.B., and de Wolff F.A. Arsenic neurotoxicity-a review. Hum. Exp. Toxicol. 26 (2007) 823-832
3. Centeno J.A., Mullick F.G., Martinez L., Page N.P., Gibb H., Longfellow D., Thompson C., and Ladich E.R. Pathology related to chronic arsenic exposure. Environ. Health Perspect. 110 (2002) 883-886
4. Greenberg S.A. Acute demyelinating polyneuropathy with arsenic ingestion. Muscle Nerve. 19 (1996) 1611-1613
5. Le Quesne P.M., and McLeod J.G. Peripheral neuropathy following a single exposure to arsenic, Clincal course in four patients with electrophysiological and histological studies. J. Neurol. Sci. 32 (1977) 437-451
6. Goebel H.H., Schmidt P.F., Bohl J., Tettenborn B., Kramer G., and Gutmann L. Polyneuropathy due to acute arsenic intoxication: biopsy studies. JNEN 49 (1990) 137-149
7. Hafeman D.M., Ahsan H., Louis E.D., Siddique A.B., Slavkovich V., Cheng Z., van Geen A., and Graziano J.H. Association between arsenic exposure and a measure of subclinical sensory neuropathy in Bangladesh. J. Occup. Environ. Med. 47 (2005) 778-784
8. Lagerkvist B.J., and Zetterlund B. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am. J. Ind. Med. 25 (1994) 477-488
9. Alberts B., Bray D., Lewis J., Raff M., Roberts K., and Watson J.D. The cytoskeleton. Molecular Biology of the Cell. Third Edition (1994), Garland Publishing, New York pp. 787-861
10. Dowjat W.K., Wisniewski H., and Wisniewski T. Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience 103 (2001) 1-8
11. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D., and Lee V.M. Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3 (1993) 45-54
12. Schechter R., Beju D., and Mille K.E. The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem. Biophys. Res. Commun. 334 (2005) 979-986
13. Lariviere R.C., and Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
14. Winship K.A. Toxicity of inorganic arsenic salts. Adverse Drug React. Acute Poisoning Rev. 3 (1984) 129-160
15. Alonso A.C., Grundke-Iqbal I., and Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2 (1996) 783-787
16. Zhu Q., Couillard-Despres S., and Julien J.P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148 (1997) 299-316
17. Dubois M., Strazielle C., Julien J.P., and Lalonde R. Mice with the deleted neurofilament of low molecular weight (Nefl) gene: 2. Effects on motor functions and spatial orientation. J. Neurosci. Res. 80 (2005) 751-758
18. Vahidnia A., Romijn F., Tiller M., van der Voet G.B., and de Wolff F.A. Arsenic-induced toxicity: effect on protein composition in sciatic nerve. Hum. Exp. Toxicol. 25 (2006) 667-674
19. Vahidnia A., van der Straaten R.J.H.M., Romijn F., van Pelt J., van der Voet G.B., and de Wolff F.A. Mechanism of arsenic-induced neurotoxicity may be explained through cleavage of p35 to p25 by calpain. Toxicol. In Vitro 22 (2008) 682-687
20. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol. Appl. Pharmacol. 220 (2007) 292-301
21. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
22. Miller C.C., Ackerley S., Brownlees J., Grierson A.J., Jacobsen N.J., and Thornhill P. Axonal transport of neurofilaments in normal and disease states. Cell Mol. Life Sci. 59 (2002) 323-330
23. Nagaraja T.N., and Desiraju T. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam. Toxicol. 50 (1993) 100-107
24. García-Chávez E., Jiménez I., Segura B., and Del Razo L.M. Lipid oxidative damage and distribution of inorganic arsenic and its metabolites in the rat nervous system after arsenite exposure: influence of alpha tocopherol supplementation. Neurotoxicology 26 (2006) 1024-1031
25. Oudega M., Voormolen J.H., Usunoff K.G., Marani E., and Thomeer R.T. Immunocytochemical localization of neurofilaments in the fibre systems of the developing rat spinal cord white matter. Eur. J. Morphol. 34 (1996) 329-346
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. DeFuria J., and Shea T.B. Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments: roles of JNK and GSK-3beta. Brain Res. 1181 (2007) 74-82
28. Carpenter D.A., and Ip W. Neurofilament triplet protein interactions: evidence for the preferred formation of NF-L-containing dimers and a putative function for the end domains. J. Cell Sci. 109 (1996) 2493-2498
29. Vahidnia A., van der Straaten R.J.H.M., Romijn F., van Pelt J., van der Voet G.B., and de Wolff F.A. Arsenic metabolites affect expression of the neurofilament and tau genes: an in-vitro study into the mechanism of arsenic neurotoxicity. Toxicol. In Vitro 21 (2007) 1104-1112
30. Ray S.K., Fidan M., Nowak M.W., Wilford G.G., Hogan E.L., and Banik N.L. Oxidative stress and Ca2+ influx upregulate calpain and induce apoptosis in PC12 cells. Brain Res. 852 (2000) 326-334
31. Kunz S., Niederberger E., Ehnert C., Coste O., Pfenninger A., Kruip J., Wendrich T.M., Schmidtko A., Tegeder I., and Geisslinger G. The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia. Pain 110 (2004) 409-418
32. Lopez-Picon F.R., Kukko-Lukjanov T.K., and Holopainen I.E. The calpain inhibitor MDL-28170 and the AMPA/KA receptor antagonist CNQX inhibit neurofilament degradation and enhance neuronal survival in kainic acid-treated hippocampal slice cultures. Eur. J. Neurosci. 23 (2006) 2686-2694
33. Zhang H., Duncan G., Wang L., Liu P., Cui H., Reddan J.R., Yang B.F., and Wormstone I.M. Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp. Eye Res. 85 (2007) 825-835
34. Hoffman P.N., and Lasek R.J. The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons. J. Cell Biol. 66 (1975) 351-366
35. Schlaepfer W.W. Neurofilaments: structure, metabolism and implications in disease. J. Neuropathol. Exp. Neurol. 46 (1987) 117-129
36. Plyte S.E., Hughes K., Nikolakaki E., Pulverer B.J., and Woodgett J.R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114 (1992) 147-162